What is the potential of immunotherapy for Pseudomonas aeruginosa infections?

Jul 5, 2018 ... aeruginosa. For many people, a Pseudomonas infection will only cause mild symptoms. However, if a person is in a hospital or has a weakened ... Aug 8, 2023 ... Its predilection to cause infections among immunocompromised hosts, extreme versatility, antibiotic resistance, and a wide range of dynamic ... Antibiotics with a novel mode of action will be needed to avoid cross resistance against currently used therapeutic agents. Importantly, antivirulence drugs are ... Nov 5, 2024 ... Pseudomonas aeruginosa has become an important cause of infection, especially in patients with compromised host defense mechanisms. It is the ... Sep 7, 2000 ... We conducted an epidemiologic and molecular investigation of endemic P. aeruginosa infection among infants in a neonatal intensive care unit. Pseudomonas aeruginosa strain Boston 41501 was isolated from blood culture. This whole-genome sequenced bacterial strain has applications in media and ... Pseudomonas aeruginosa infections are the predominant driver of CF lung disease, and airway isolates are frequently resistant to multiple antimicrobials ... Jan 20, 2023 ... Pseudomonas aeruginosa is an opportunistic pathogen that requires iron for growth and virulence, yet this nutrient is sequestered by the ... Pseudomonas aeruginosa is commonly found transiently on the skin, especially in the axillary and anogenital regions, and readily colonises ulcers and moist ... Dec 16, 2024 ... ... infection due to P aeruginosa. Secondary outcomes included all ... Pseudomonas aeruginosa infection. Infect Drug Resist. 2022; 15:655 ...